Skip to main content

WPI 2533 Pill - white oval, 13mm

Pill with imprint WPI 2533 is White, Oval and has been identified as Dalfampridine Extended-Release 10 mg. It is supplied by Teva Pharmaceuticals USA, Inc.

Dalfampridine is used in the treatment of Multiple Sclerosis and belongs to the drug class miscellaneous central nervous system agents. Risk cannot be ruled out during pregnancy. Dalfampridine 10 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for WPI 2533

Dalfampridine extended-release 10 mg WPI 2533

Dalfampridine Extended-Release

Imprint
WPI 2533
Strength
10 mg
Color
White
Size
13.00 mm
Shape
Oval
Availability
Prescription only
Drug Class
Miscellaneous central nervous system agents
Pregnancy Category
C - Risk cannot be ruled out
CSA Schedule
Not a controlled drug
Labeler / Supplier
Teva Pharmaceuticals USA, Inc.
National Drug Code (NDC)
00591-2533

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.